ADC Therapeutics SA
ADCT
$3.43
-$0.05-1.44%
NYSE
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 14.60% | 79.14% | 6.83% | -55.01% | 17.17% |
| Total Depreciation and Amortization | -75.16% | -85.75% | -84.79% | 0.24% | -45.55% |
| Total Amortization of Deferred Charges | 17.80% | 144.17% | 42.05% | 47.73% | -62.03% |
| Total Other Non-Cash Items | -28.82% | -872.19% | 11.27% | 117.15% | 0.41% |
| Change in Net Operating Assets | 83.04% | -215.48% | -95.41% | 418.47% | -197.44% |
| Cash from Operations | 47.26% | -42.43% | -18.32% | 26.66% | -27.76% |
| Capital Expenditure | 87.88% | 100.00% | 100.00% | 100.00% | 50.28% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 87.88% | 832.22% | 100.00% | 100.00% | 50.28% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -24.35% | 135,604.65% | -- | -4.73% | -23.88% |
| Repurchase of Common Stock | -- | -8.68% | 77.47% | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -315.13% | 5,197.23% | 77.47% | -4.98% | -23.88% |
| Foreign Exchange rate Adjustments | -103.11% | 92.71% | -97.94% | 1,258.33% | 474.42% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 46.00% | 213.65% | -15.38% | 6.11% | -26.75% |